title: Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.
authors.forename: Yvette
authors.initials: Y
authors.lastname: Drew
authors.forename: Jonathan
authors.initials: J
authors.lastname: Ledermann
authors.forename: Geoff
authors.initials: G
authors.lastname: Hall
authors.forename: Daniel
authors.initials: D
authors.lastname: Rea
authors.forename: Ros
authors.initials: R
authors.lastname: Glasspool
authors.forename: Martin
authors.initials: M
authors.lastname: Highley
authors.forename: Gordon
authors.initials: G
authors.lastname: Jayson
authors.forename: Julieann
authors.initials: J
authors.lastname: Sludden
authors.forename: James
authors.initials: J
authors.lastname: Murray
authors.forename: David
authors.initials: D
authors.lastname: Jamieson
authors.forename: Sarah
authors.initials: S
authors.lastname: Halford
authors.forename: Gary
authors.initials: G
authors.lastname: Acton
authors.forename: Zoe
authors.initials: Z
authors.lastname: Backholer
authors.forename: Raffaella
authors.initials: R
authors.lastname: Mangano
authors.forename: Alan
authors.initials: A
authors.lastname: Boddy
authors.forename: Nicola
authors.initials: N
authors.lastname: Curtin
authors.forename: Ruth
authors.initials: R
authors.lastname: Plummer